Navigation Links
Research on Crucial Role of PET-Guided Biopsy in Initial Breast Cancer Diagnosis and Presurgical Planning Published in The Breast Journal
Date:3/31/2011

SAN DIEGO, March 31, 2011 /PRNewswire/ -- The Breast Journal recently published original prospective data confirming the technical validity of image-guided needle biopsy of suspicious breast cancer lesions using Positron Emission Mammography (PEM)-guidance.  The study, which used the Naviscan high-resolution breast PET scanner, otherwise known as a PEM scanner, marks the first time PET imaging alone has been able to target regions in the breast with abnormal FDG uptake and guide the extraction for histopathologic analysis.

The main objective of the study was to confirm successful targeting and lesion sampling.  A second objective was to confirm the safety and patient comfort during the procedure. Six physicians, using three different commercially available vacuum-assisted biopsy tools, conducted this study at five sites.  A total of 24 PEM-guided biopsies were completed with 100% success.

The most important advantage of PEM-guided biopsy is the ability to target and biopsy lesions that are difficult to see on other imaging tools giving patients and physicians another option in the fight against breast cancer.  "I am so thankful that I was able to have this procedure," stated Sally Ryser, a patient from Boca Raton, Florida who participated in the study. "The type of cancer that I had is called triple negative and apparently is a very aggressive form of cancer.  Had I not had the PEM scan and the PEM biopsy, who knows what my prognosis would have been had the cancer not been detected.  I truly feel that these innovative PEM procedures most likely saved my life."

"PEM-guided biopsy is quite elegant and confers several advantages over MRI-guided biopsy," stated Dr. Wendie Berg, a co-author of the paper. "We can easily image the breast after sampling to assure removal of the target, and resample at the same setting if needed.  With PEM, we also have the ability to directly image the specimens, which both further confirms successful sampling and allows us to direct the pathologist's attention to the 'hot' specimens."

About Naviscan, Inc.

Naviscan, founded in 1995, develops and markets compact, high-resolution PET scanners intended to provide organ-specific molecular imaging and guide radiological and surgical procedures. The Naviscan PEM scanner is currently installed and available in breast and imaging centers throughout the U.S. and other parts of the world. The Company is headquartered in San Diego, California and is the first to obtain FDA-clearance for a high-resolution PET scanner designed to image small body parts and for breast biopsy image guidance.  For more information, call 1.858.587.3641 or visit www.naviscan.com.


'/>"/>
SOURCE Naviscan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Clinical Research Management, a Full-Service CRO, Changes Its Name to ClinicalRM
2. Southern Research Scientists to Present New Data at the American Association for Cancer Research 102nd Annual Meeting in Orlando
3. Newborn Possibilities Fund Awards Grant to Georgia Health Sciences University Foundation to Support Groundbreaking Pediatric Research
4. Yuma Therapeutics Awarded a Research Grant by the Alzheimers Drug Discovery Foundation to Develop Novel Therapeutics for Alzheimers Disease
5. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
6. Bellicum Pharmaceuticals Awarded $5.7 Million by the Cancer Prevention and Research Institute of Texas
7. CVS Caremark Research Finds "Dispense as Written" Prescriptions May Add $7.7 Billion to Annual Health Care Costs
8. Sanofi-aventis Enters Into Research Collaboration With Columbia University to Develop New Diabetes Treatments
9. Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting
10. Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development
11. Cytel Hires Biopharmaceutical Development Veteran Jim Baker to Support Expansion of its Clinical Research Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017  The U.S. Food ... (avelumab) for the treatment of adults and pediatric patients ... (MCC), including those who have not received prior chemotherapy. ... a rare, aggressive form of skin cancer. ... cancers, patients with a rare form called Merkel cell ...
(Date:3/23/2017)... DIEGO and VANCOUVER, British Columbia ... (NASDAQ: SPHS ) (the "Company" or "Sophiris"), ... the treatment of urological diseases, today announced that data ... evaluated the drug as a focal treatment for localized ... March 26, 2017 at the 32 nd Annual ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and ... Devices Market 2017-2021" report to their offering. ... The global oxygen therapy devices ... 2017-2021. The report, Global Oxygen Therapy Devices Market ... inputs from industry experts. The report covers the market landscape and ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... ... March is National Kidney Month – the perfect time to pause and thank ... Every day, two kidneys filter about 120 to 150 quarts of blood. Put another ... regulating fluid levels and blood pressure, supporting bone health and promoting red blood cell ...
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company announced ... The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive ... that have excellent programs for the delivery and improvement of disease management and ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... educational training program owned and organized by HMP Communications Holdings, LLC, today announced ... for physicians within its nationwide network of wound centers interested in becoming Certified ...
(Date:3/23/2017)... CO (PRWEB) , ... March 23, 2017 , ... ... serving the families and businesses of the greater Fort Collins area, has unveiled ... in their ongoing community involvement program. Donations to this worthy cause may now ...
(Date:3/23/2017)... ... , ... After raising more than $1.135 million ($1,479,231 AUD) from nearly 20,000 ... in crowdfunding history, has established a U.S. Headquarters in New York City, FaceCradle USA, ... “We’re excited to be operating on U.S. shores, where most of our initial crowdfunding ...
Breaking Medicine News(10 mins):